Clinical Trials List
Protocol NumberEPOC1905
Completed
2020-06-16 - 2024-11-30
Phase III
Recruiting1
ICD-10C18.9
Malignant neoplasm of colon, unspecified
ICD-10C7A.029
Malignant carcinoid tumor of the large intestine, unspecified portion
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.9
Malignant neoplasm of colon, unspecified
-
Trial Applicant
GEORGE CLINICAL ASIA PACIFIC LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- 梁逸歆 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Been Ren Lin Division of General Surgery
- 陳姿君 Division of General Surgery
- Kun-Huei Yeh Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- JIN-TUNG LIANG Division of General Surgery
- 賴碩倫 Division of General Surgery
- 揚士弘 Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 洪基翔 Division of General Surgery
- 陳國興 Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- 黃約翰 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
240 participants
